Mareska; David A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mareska; David A..The latest application filed is for "benzoimidazol-1,2-yl amides as kv7 channel activators".

Company Profile

7.24.23

Mareska; David A. - McMurray PA
Mareska; David A. - Boulder CO US
Mareska; David A. - Longmont CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
KV7 channel activators compositions and methods of use Grant 11,261,162 - Bozik , et al. March 1, 2	2022-03-01
BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS App 20210188782 - RESNICK; Lynn ; et al.	2021-06-24
Kv7 Channel Activators Compositions And Methods Of Use App 20210130299 - BOZIK; Michael E. ; et al.	2021-05-06
Benzoimidazol-1,2-yl amides as Kv7 channel activators Grant 10,906,877 - Resnick , et al. February 2, 2	2021-02-02
Kv7 channel activators compositions and methods of use Grant 10,851,067 - Bozik , et al. December 1, 2	2020-12-01
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 10,669,269 - Boys , et al.	2020-06-02
BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS App 20200062714 - RESNICK; Lynn ; et al.	2020-02-27
Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators Grant 10,526,328 - Resnick , et al. J	2020-01-07
BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS App 20200002292 - RESNICK; Lynn ; et al.	2020-01-02
Kv7 Channel Activators Compositions And Methods Of Use App 20190284142 - BOZIK; Michael E. ; et al.	2019-09-19
Benzoimidazol-1,2-yl amides as Kv7 channel activators Grant 10,385,025 - Resnick , et al. A	2019-08-20
Imidazo[4,5-b]pyridin-2-yl Amides As Kv7 Channel Activators App 20190002464 - RESNICK; Lynn ; et al.	2019-01-03
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators Grant 10,106,536 - Resnick , et al. October 23, 2	2018-10-23
BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS App 20180148419 - RESNICK; Lynn ; et al.	2018-05-31
SUBSTITUTED N-(lH-INDAZOL-4-YL)IMIDAZO[l,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS App 20180086758 - Boys; Mark Laurence ; et al.	2018-03-29
Benzoimidazol-1,2-yl amides as Kv7 channel activators Grant 9,914,708 - Harried , et al. March 13, 2	2018-03-13
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 9,809,590 - Boys , et al. November 7, 2	2017-11-07
Imidazo(4,5-b) Pyridin-2-yl Amides As Kv7 Channel Activators App 20170240547 - Resnick; Lynn ; et al.	2017-08-24
Imidazo(4,5-B) pyridin-2-yl amides as K.sub.V7 channel activators Grant 9,650,376 - Resnick , et al. May 16, 2	2017-05-16
BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS App 20170114022 - Harried; Scott S. ; et al.	2017-04-27
Benzoimidazol-1,2-yl amides as Kv7 channel activators Grant 9,481,653 - Resnick , et al. November 1, 2	2016-11-01
BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS App 20160075663 - Resnick; Lynn ; et al.	2016-03-17
Imidazo(4,5-b) Pyridin-2-yl Amides As Kv7 Channel Activators App 20160031875 - Resnick; Lynn ; et al.	2016-02-04
SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS App 20160002232 - Boys; Mark Laurence ; et al.	2016-01-07
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 9,174,981 - Boys , et al. November 3, 2	2015-11-03
Piperidine-containing compounds and use thereof Grant 8,809,538 - Rodriguez , et al. August 19, 2	2014-08-19
Piperidinyl-substituted lactams as GPR119 modulators Grant 8,754,226 - Aicher , et al. June 17, 2	2014-06-17
Substituted N-(1h-indazol-4-yl)imidazo[1,2-]pyridine-3-carboxamide Compounds As Type Iii Receptor Tyrosine Kinase Inhibitors App 20130274244 - Boys; Mark Laurence ; et al.	2013-10-17
P38 inhibitors and methods of use thereof Grant 8,518,983 - Munson , et al. August 27, 2	2013-08-27
Piperidine-containing Compounds And Use Thereof App 20110275608 - Rodriguez; Martha E. ; et al.	2011-11-10
P38 inhibitors and methods of use thereof Grant 8,017,641 - Munson , et al. September 13, 2	2011-09-13
P38 inhibitors and methods of use thereof Grant 7,799,782 - Munson , et al. September 21, 2	2010-09-21
P38 Inhibitors And Methods Of Use Thereof App 20090149459 - Munson; Mark ; et al.	2009-06-11
P38 Inhibitors And Methods Of Use Thereof App 20090143422 - Munson; Mark ; et al.	2009-06-04
P38 Inhibitors And Methods Of Use Thereof App 20090136596 - Munson; Mark ; et al.	2009-05-28
P38 inhibitors and methods of use thereof Grant 7,521,447 - Munson , et al. April 21, 2	2009-04-21
Compounds And Methods Of Use App 20090048224 - Groneberg; Robert D. ; et al.	2009-02-19
Compounds and methods of use Grant 7,425,631 - Groneberg , et al. September 16, 2	2008-09-16
Preparation of phosphatase inhibitors Grant 7,078,425 - Groneberg , et al. July 18, 2	2006-07-18
Preparation of phosphatase inhibitors App 20050256316 - Groneberg, Robert D. ; et al.	2005-11-17
Compounds and methods of use App 20050124654 - Groneberg, Robert D. ; et al.	2005-06-09
P38 inhibitors and methods of use thereof App 20040192653 - Munson, Mark ; et al.	2004-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.